NIH

June 30, 2017

Cytokine linked to blindness

A signaling molecule called interleukin-6 may be a therapeutic target to prevent vision loss or nerve degeneration in glaucoma, Vanderbilt researchers have discovered.

By Meredith Jackson
June 29, 2017

Team investigates antiviral that inhibits SARS, MERS

A new antiviral drug candidate inhibits a broad range of coronaviruses, including the SARS and MERS coronaviruses, a multi-institutional team of investigators reports this week in Science Translational Medicine.

By Leigh MacMillan
June 29, 2017

Genetics of lung cancer survival

Vanderbilt investigators have conducted a first-of-its-kind genome-wide association study of lung cancer survival in African-Americans.

By Sanjay Mishra
bees
June 19, 2017

STINGing combination for cancer

A novel immunotherapy combination induced remarkable regression of tumors in a mouse model of head and neck cancer.

By VUMC News and Communications
Insulin in vials
June 15, 2017

VUMC team’s discovery could lead to new diabetes treatment

By Bill Snyder
June 14, 2017

PET imaging to predict tumor response

A PET probe that detects the amino acid glutamine predicts whether tumors respond to certain targeted therapies in preclinical animal models.

By Leigh MacMillan
June 12, 2017

Repriming replication roadblocks

New findings shed light on how enzymes that replicate DNA skip over mutations that might cause cancer and restart DNA synthesis further away.
By Sanjay Mishra
June 9, 2017

Flip side of gut protection

Vanderbilt investigators report that dysregulation of certain immune cells in the intestines may lead to inflammation and disease.
By Laura Daniel
June 8, 2017

VUMC lands renewal of Clinical and Translational Science Award

Vanderbilt University Medical Center (VUMC) has competed successfully for a second renewal of its Clinical and Translational Science Award (CTSA) by the National Institutes of Health (NIH).
By Bill Snyder
June 8, 2017

NIDDK renews Vanderbilt’s diabetes research grant

The Vanderbilt Diabetes Research and Training Center (VDRTC) is celebrating its 44th year of operation with a five-year competitive renewal of its $9 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH).
By Jill Clendening
May 26, 2017

Preserving NIH’s Fogarty International Center crucial for global health efforts

This week Douglas Heimburger, M.D., M.S., professor of Medicine at Vanderbilt, joined a growing chorus calling for preservation of the Fogarty International Center of the National Institutes of Health (NIH).
By Bill Snyder
May 18, 2017

Oxidative stress in tumors

Vanderbilt investigators have developed a new method for measuring oxidative stress in human tumors, which provides insight into cancer development.
By Sanjay Mishra
May 15, 2017

RSV-HRV viral interference

RSV infection reduces the risk of infection with human rhinovirus, which could have implications for vaccine development and prevention strategies for viral respiratory tract infections in infants.
By Leigh MacMillan
1 … 45 46 47 48 49 … 101